Dr. Cassian Yee, M.D. associate member, clinical research division, Fred Hutchinson Cancer Research Center, Seattle
Dr. Yee could you email a copy of this paper.
I had e-mail Dr. Yee on 12-9-2008 for his paper
I am a cancer patient (50 yrs. old) under the care of Dr. John Kirkwood at the Hillman Cancer Center at the University of Pittsburgh. I have gone through a wide incision, lymph nodes removal, Interferon therapy, and Dicarbazine therapy and CTLA-4 without success. I am presently washed out an IL-2 clinical trial that started in November 1, 2006. On the fourth cycle I had a heart attack and the doctors determined to abort the IL-2 on February 2, 2007. On August 23 there was no change to the tumors in my back or lungs but also no growth. In October 24 I got the word that the tumors and the lung nodules were shrinking. In April 14, 2008, the 40 + nodules in my lungs decrease to 2. In July 2008, the nodules in my lungs were undetectable and the ones on my back were all but one gone. Presently, I am due for another round of CT and MRI most likely for a restaging (NED)
July (2005)I was riding my bicycle to work at the Eastman Kodak Research Labs about 3 miles from home. I was wearing a knapsack to carry my things to and from the labs. I started noticing an ache on my back. I asked my wife to take a look at it. It was just a mole. So I decide to go to the dermatologist. To make the log story short, it was cancer. It took about a month and a half to get it biopsied . (Sept. 26 2005) I contacted a surgical oncologist and on October 27 2005 I had a wide incision to remove the tumor off my back. I also had a PET scan and a sentinel lymph node biopsy done and it showed no cancer except the localized one on my back. I knew from my research that I would be needing adjuvant therapy. So I started communicating with Sloan Kettering, University of Pittsburgh Cancer Center, and a couple of others including the Hillman Cancer Center and Wilmot Cancer Center at Strong in Rochester N.Y.
I am a researcher by schooling
Thanks in advance.
FREE NEJM E-TOC HOME | SUBSCRIBE | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | Search Term Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
Previous
Volume 358:2698-2703
June 19, 2008 Number 25
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
Naomi N. Hunder, M.D., Herschel Wallen, M.D., Jianhong Cao, Ph.D., Deborah W. Hendricks, B.Sc., John Z. Reilly, B.Sc., Rebecca Rodmyre, B.Sc., Achim Jungbluth, M.D., Sacha Gnjatic, Ph.D., John A. Thompson, M.D., and Cassian Yee, M.D.
SOURCES: Cassian Yee, M.D., associate member, clinical research division, Fred Hutchinson Cancer Research Center, Seattle; Louis M. Weiner, M.D., director, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C.; Vijay Trisal, M.D., assistant professor of surgical oncology, City of Hope Cancer Center, Duarte, Calif.; June 19, 2008, New England Journal of Medicine
Yessssssssss!!!!!!!!!!! I was on to Something BIG!!!!!!!!!!!!!
Response from Dr. Yee
yes
Cassian Yee MD
Associate Member
Fred Hutchinson Cancer Research Center
Seattle, WA 98109
206 667 6287 voice
206 667 7983 fax
cyee@fhcrc.org
I have That PAPER!!!!!!!!!!!!!!!!!!!!!!!!!!!
Jimmy B
No comments:
Post a Comment